These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8545902

  • 21. Survival of MHC-deficient mouse heterotopic cardiac allografts.
    Campos L, Naji A, Deli BC, Kern JH, Kim JI, Barker CF, Markmann JF.
    Transplantation; 1995 Jan 27; 59(2):187-91. PubMed ID: 7839439
    [Abstract] [Full Text] [Related]

  • 22. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI, Khleif SN, Bergmann-Leitner ES, Kantor JA, Chung Y, Hamilton JM, Schlom J.
    Cell Immunol; 1997 Dec 15; 182(2):137-51. PubMed ID: 9514698
    [Abstract] [Full Text] [Related]

  • 23. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
    Bristol JA, Orsini C, Lindinger P, Thalhamer J, Abrams SI.
    Cell Immunol; 2000 Nov 01; 205(2):73-83. PubMed ID: 11104579
    [Abstract] [Full Text] [Related]

  • 24. Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection.
    Oukka M, Galou M, Belkaid Y, Tricotet V, Riche N, Reynes M, Kosmatopoulos K.
    Eur J Immunol; 1997 Dec 01; 27(12):3499-506. PubMed ID: 9464840
    [Abstract] [Full Text] [Related]

  • 25. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
    Beilke J, Johnson Z, Kuhl N, Gill RG.
    Transplant Proc; 2004 May 01; 36(4):1173-4. PubMed ID: 15194406
    [Abstract] [Full Text] [Related]

  • 26. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ, Lovegrove E, Bradley JA, Maclean J, Bolton EM.
    J Immunol; 1998 Aug 01; 161(3):1292-8. PubMed ID: 9686590
    [Abstract] [Full Text] [Related]

  • 27. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA, Flye MW.
    Surgery; 2005 Aug 01; 138(2):141-9. PubMed ID: 16153420
    [Abstract] [Full Text] [Related]

  • 28. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
    Taylor AL, Negus SL, Negus M, Bolton EM, Bradley JA, Pettigrew GJ.
    Transplantation; 2007 Apr 15; 83(7):931-7. PubMed ID: 17460565
    [Abstract] [Full Text] [Related]

  • 29. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.
    Sayeh E, Aslam R, Speck ER, Le-Tien H, Lazarus AH, Freedman J, Semple JW.
    Transfusion; 2004 Nov 15; 44(11):1572-8. PubMed ID: 15504162
    [Abstract] [Full Text] [Related]

  • 30. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA, Flye MW.
    J Surg Res; 2005 Jun 15; 126(2):160-6. PubMed ID: 15919414
    [Abstract] [Full Text] [Related]

  • 31. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
    Alexander-Miller MA, Burke K, Koszinowski UH, Hansen TH, Connolly JM.
    J Immunol; 1993 Jul 01; 151(1):1-10. PubMed ID: 8392095
    [Abstract] [Full Text] [Related]

  • 32. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection.
    Brown CR, McLeod R.
    J Immunol; 1990 Nov 15; 145(10):3438-41. PubMed ID: 2121825
    [Abstract] [Full Text] [Related]

  • 33. Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the alpha 3 domain of MHC I molecules.
    Aldrich CJ, Hammer RE, Jones-Youngblood S, Koszinowski U, Hood L, Stroynowski I, Forman J.
    Nature; 1991 Aug 22; 352(6337):718-21. PubMed ID: 1652099
    [Abstract] [Full Text] [Related]

  • 34. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
    Fassanito MA, Loftus D, De Leo RM, Law LW, Appella E, De Leo AB.
    Cancer Res; 1994 Aug 15; 54(16):4424-9. PubMed ID: 7519121
    [Abstract] [Full Text] [Related]

  • 35. Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejection.
    Tjoa BA, Kranz DM.
    Cancer Res; 1994 Jan 01; 54(1):204-8. PubMed ID: 7505197
    [Abstract] [Full Text] [Related]

  • 36. Masking of veto function in vivo by activated CD4+ T lymphocytes.
    Rammensee HG, Hügin D.
    Eur J Immunol; 1989 Apr 01; 19(4):643-8. PubMed ID: 2567242
    [Abstract] [Full Text] [Related]

  • 37. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation.
    Dalchau R, Fangmann J, Fabre JW.
    Eur J Immunol; 1992 Mar 01; 22(3):669-77. PubMed ID: 1547813
    [Abstract] [Full Text] [Related]

  • 38. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.
    Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H.
    J Exp Med; 1994 Mar 01; 179(3):865-72. PubMed ID: 8113680
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection.
    Fangmann J, Dalchau R, Sawyer GJ, Priestley CA, Fabre JW.
    Eur J Immunol; 1992 Jun 01; 22(6):1525-30. PubMed ID: 1601039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.